Scarica l'app Stockscreener
56.81
1.59%
0.89
Pre-mercato:
56.55
-0.26
-0.46%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$55.92
Aprire:
$56.47
Volume 24 ore:
22.60M
Relative Volume:
1.39
Capitalizzazione di mercato:
$84.44B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
23.82
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
+5.01%
1M Prestazione:
-11.55%
6M Prestazione:
-41.44%
1 anno Prestazione:
-46.74%
Intervallo 1D:
$56.24
$57.59
Intervallo di 1 settimana:
$52.52
$57.59
Portata 52W:
$52.52
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
56.81 | 83.12B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
88.82 | 153.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
317.75 | 120.08B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.58 | 99.27B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
82.16 | 47.44B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Corp. stock (US10117L1017): market eyes next catalysts after recent updates - AD HOC NEWS
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results - Benzinga
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial - Yahoo Finance
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Yahoo Finance
Boston Scientific coronary device meets trial endpoints - Investing.com
Boston Scientific posts positive data for coronary IVL catheter - Yahoo Finance
Trial of new heart device leaves 93% free of major cardiac events - Stock Titan
Boston Scientific invests $1.5bn for equity stake in MiRus - Yahoo Finance
Boston Scientific Corp (BSX) Stock Up 6.2% and Still Undervalued -- GF Score: 83/100 - GuruFocus
Boston Scientific stock (US10117L1017): New catalyst watch after recent company developments - AD HOC NEWS
Boston Scientific Pairs US$2b Buyback With MiRus TAVR Growth Bet - Yahoo Finance
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corp Stock (BSX) Closed Up by 5.88% on May 18: Facts Behind the Movement - TradingKey
Boston Scientific invests $1.5B in MiRus heart valve startup - Yahoo Finance
Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal - Benzinga
BSX Reiterated by Needham -- Price Target Maintained at $77.00 - GuruFocus
Boston Scientific Bets on Growth Through Strategic M&A Deals - Yahoo Finance
Boston Scientific (BSX) Invests $1.5B in MiRus for 34% Equity St - GuruFocus
Boston Scientific returns to heart-valve market with $1.5B investment in startup - The Business Journals
Boston Scientific Invests $1.5 Billion in MiRus for Exclusive Option on Innovative Nickel-Free Balloon Expandable TAVR Valve - Minichart
Boston Scientific Announces $2 Billion Accelerated Share Repurchase Agreement to Boost Shareholder Value - Minichart
Truist reiterates Boston Scientific stock rating on MiRus deal - Investing.com
Boston Scientific (BSX) Invests $1.5B in MiRus for Cardiovascula - GuruFocus
Why is Boston Scientific stock rallying today? - Investing.com
Boston Sci invests $1.5B in Mirus, gains option for TAVR system - BioWorld News
Boston Scientific shares rise after $1.5B MiRus investment and $2B accelerated buyback - Quiver Quantitative
Boston Scientific shares rise after $2 billion buyback and MiRus investment (BSX) - MSN
Boston Scientific (BSX) Announces $2 Billion Accelerated Share R - GuruFocus
Boston Scientific Shares Rise After $2 Billion Buyback and MiRus Investment (BSX) - Yahoo Finance
Boston Scientific stock gains on $2B share buyback plan - Investing.com
Here’s Why Boston Scientific’s Stock (BSX) Is Surging Today - TipRanks
Boston Scientific buys 34% stake in MiRus for $1.5bn - Sharecast.com
Boston Scientific invests $1.5 billion in MiRus with option to buy heart-valve business - Reuters
Boston Scientific (NYSE: BSX) starts $2B accelerated share repurchase program - Stock Titan
Boston Scientific (NYSE: BSX) commits $1.5B plus $3B option for MiRus TAVR business - Stock Titan
Boston Scientific invests $1.5B in MiRus for 34% stake By Investing.com - Investing.com
Boston Scientific enters into $2 billion accelerated share repurchase agreement - Yahoo! Finance Canada
Boston Scientific's $1.5B nickel-free heart valve deal with $3B option - Stock Titan
Boston Scientific stock (US10117L1017): Q1 earnings beat and raised 2026 outlook - AD HOC NEWS
Boston Scientific Corp. stock (US10117L1017): focus on latest earnings and growth drivers - AD HOC NEWS
May Hill Capital LLC Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific's big dip could be a bigger opportunity - MSN
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific plunges 43% YTD amid weak outlook but shows potential for recovery with new Buy rating. - Pluang
Boston Scientific Corp. stock (US10117L1017): recent earnings, device pipeline and outlook - AD HOC NEWS
Why this $23-billion money manager is buying Caterpillar and selling Boston Scientific - The Globe and Mail
Boston Scientific Corporation $BSX Stock Position Lifted by Bessemer Group Inc. - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Decreased by AustralianSuper Pty Ltd - MarketBeat
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.63%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):